GILEAD SCIENCES INC (1GILD.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1GILD - US3755581036 - Common Stock
103.52 EUR
-2.36 (-2.23%)
We assign a fundamental rating of 6 out of 10 to 1GILD. 1GILD was compared to 81 industry peers in the Biotechnology industry. While 1GILD has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on 1GILD. 1GILD also has an excellent dividend rating. These ratings could make 1GILD a good candidate for value and dividend investing.
1. Profitability
1.1 Basic Checks
In the past year 1GILD was profitable.
1GILD had a positive operating cash flow in the past year.
1GILD had positive earnings in each of the past 5 years.
Each year in the past 5 years 1GILD had a positive operating cash flow.
1.2 Ratios
1GILD has a Return On Assets of 13.86%. This is amongst the best in the industry. 1GILD outperforms 86.75% of its industry peers.
1GILD has a better Return On Equity (37.80%) than 97.59% of its industry peers.
Looking at the Return On Invested Capital, with a value of 18.54%, 1GILD belongs to the top of the industry, outperforming 95.18% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1GILD is above the industry average of 11.80%.
The 3 year average ROIC (16.22%) for 1GILD is below the current ROIC(18.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.86% | ||
| ROE | 37.8% | ||
| ROIC | 18.54% |
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1.3 Margins
Looking at the Profit Margin, with a value of 27.88%, 1GILD belongs to the top of the industry, outperforming 85.54% of the companies in the same industry.
1GILD's Profit Margin has declined in the last couple of years.
The Operating Margin of 1GILD (38.96%) is better than 95.18% of its industry peers.
1GILD's Operating Margin has improved in the last couple of years.
1GILD's Gross Margin of 78.72% is fine compared to the rest of the industry. 1GILD outperforms 67.47% of its industry peers.
1GILD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.96% | ||
| PM (TTM) | 27.88% | ||
| GM | 78.72% |
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1GILD is creating value.
The number of shares outstanding for 1GILD remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 1GILD has less shares outstanding
Compared to 1 year ago, 1GILD has a worse debt to assets ratio.
2.2 Solvency
There is no outstanding debt for 1GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC2.28
WACC8.14%
2.3 Liquidity
A Current Ratio of 1.53 indicates that 1GILD should not have too much problems paying its short term obligations.
1GILD has a Current ratio of 1.53. This is in the lower half of the industry: 1GILD underperforms 61.45% of its industry peers.
A Quick Ratio of 1.17 indicates that 1GILD should not have too much problems paying its short term obligations.
1GILD has a Quick ratio of 1.17. This is in the lower half of the industry: 1GILD underperforms 65.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
1GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.88%, which is quite impressive.
The Earnings Per Share has been decreasing by -7.01% on average over the past years.
The Revenue has been growing slightly by 2.78% in the past year.
The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
3.2 Future
Based on estimates for the next years, 1GILD will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.55% on average per year.
Based on estimates for the next years, 1GILD will show a small growth in Revenue. The Revenue will grow by 4.01% on average per year.
EPS Next Y80.6%
EPS Next 2Y38.7%
EPS Next 3Y27.13%
EPS Next 5Y19.55%
Revenue Next Year3.16%
Revenue Next 2Y3.13%
Revenue Next 3Y3.74%
Revenue Next 5Y4.01%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.89, 1GILD is valued correctly.
1GILD's Price/Earnings ratio is rather cheap when compared to the industry. 1GILD is cheaper than 87.95% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1GILD to the average of the S&P500 Index (26.51), we can say 1GILD is valued slightly cheaper.
1GILD is valuated correctly with a Price/Forward Earnings ratio of 13.76.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1GILD indicates a rather cheap valuation: 1GILD is cheaper than 93.98% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. 1GILD is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.89 | ||
| Fwd PE | 13.76 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1GILD is valued cheaper than 85.54% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1GILD is valued cheaply inside the industry as 87.95% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.9 | ||
| EV/EBITDA | 10.07 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1GILD has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1GILD's earnings are expected to grow with 27.13% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y38.7%
EPS Next 3Y27.13%
5. Dividend
5.1 Amount
1GILD has a Yearly Dividend Yield of 2.51%. Purely for dividend investing, there may be better candidates out there.
1GILD's Dividend Yield is rather good when compared to the industry average which is at 0.74. 1GILD pays more dividend than 95.18% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, 1GILD pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.51% |
5.2 History
The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1GILD pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12%
EPS Next 2Y38.7%
EPS Next 3Y27.13%
BIT:1GILD (12/18/2025, 7:00:00 PM)
103.52
-2.36 (-2.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners91.32%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap128.44B
Revenue(TTM)29.09B
Net Income(TTM)8.11B
Analysts81.08
Price Target110.22 (6.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.51% |
Yearly Dividend2.67
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)-1.8%
PT rev (3m)0.94%
EPS NQ rev (1m)-10.1%
EPS NQ rev (3m)-12.46%
EPS NY rev (1m)1.61%
EPS NY rev (3m)0.79%
Revenue NQ rev (1m)0.28%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)1.35%
Revenue NY rev (3m)1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.89 | ||
| Fwd PE | 13.76 | ||
| P/S | 5.2 | ||
| P/FCF | 15.9 | ||
| P/OCF | 15.66 | ||
| P/B | 7.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.07 |
EPS(TTM)6.95
EY6.71%
EPS(NY)7.52
Fwd EY7.27%
FCF(TTM)6.51
FCFY6.29%
OCF(TTM)6.61
OCFY6.39%
SpS19.89
BVpS14.67
TBVpS-3.3
PEG (NY)0.18
PEG (5Y)N/A
Graham Number47.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.86% | ||
| ROE | 37.8% | ||
| ROCE | 24.51% | ||
| ROIC | 18.54% | ||
| ROICexc | 23.24% | ||
| ROICexgc | 80.87% | ||
| OM | 38.96% | ||
| PM (TTM) | 27.88% | ||
| GM | 78.72% | ||
| FCFM | 32.73% |
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 68.56% | ||
| Profit Quality | 117.39% | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | N/A |
F-Score7
WACC8.14%
ROIC/WACC2.28
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
EPS Next Y80.6%
EPS Next 2Y38.7%
EPS Next 3Y27.13%
EPS Next 5Y19.55%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
Revenue Next Year3.16%
Revenue Next 2Y3.13%
Revenue Next 3Y3.74%
Revenue Next 5Y4.01%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.48%
EBIT Next 3Y25.45%
EBIT Next 5Y19.13%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%
GILEAD SCIENCES INC / 1GILD.MI FAQ
What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.
What is the valuation status for 1GILD stock?
ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Undervalued.
Can you provide the profitability details for GILEAD SCIENCES INC?
GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.
What are the PE and PB ratios of GILEAD SCIENCES INC (1GILD.MI) stock?
The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (1GILD.MI) is 14.89 and the Price/Book (PB) ratio is 7.06.
What is the financial health of GILEAD SCIENCES INC (1GILD.MI) stock?
The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.